drugset / Trial / NCT04967170
A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus
RandomizedParallel-groupSingle-blindTreatment
Summary
The purposes of this study are to determine the safety and feasibility of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus, and to determine the efficacy of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus.
Timeline
- Start
- 2022-01-19
- Primary completion
- 2026-06-01
- Completion
- 2026-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | — | Other |